A clinical-stage US biotechnology company developing precisely targeted small molecule kinase inhibitors for cancer, with lead programs in ROS1- and ALK-positive non-small cell lung cancer.
A clinical-stage US biotechnology company developing precisely targeted small molecule kinase inhibitors for cancer, with lead programs in ROS1- and ALK-positive non-small cell lung cancer.
